Results of this study indicate that elevated plasma PAI-1 levels were associated with increasing tumor stage and disease relapse, which encourage future investigations addressing the role of plasma PAI-1 levels in the management of patients with breast cancer and in providing the rationale for new therapeutic strategies. This evidence concerns the gene SERPINE1 and breast cancer.